Oramed Pharmaceuticals Inc. (ORMP) Ownership
ORMP ownership summary
as of October 18, 2026- Institutions
- 45.1% of shares outstanding
- Insiders
- 21.27% of shares outstanding
- Shares outstanding
- 41.6M
- Float
- 29.8M shares available to trade
- Short interest
- 4.16% 1.4M shares short
- Days to cover
- 7.52 short interest up 9.6% vs prior month
- Institutions 45.10%
- Insiders 21.27%
- Other investors 33.63%
ORMP top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Mercer Global Advisors Inc. | 9.16% | 3.8M | $15.5M | +1.9M (+99.4%) | June 30, 2026 |
| 2 | Aquamarine Financial (Cayman) Ltd | 6.04% | 2.5M | $10.2M | +399,863 (+18.9%) | June 30, 2026 |
| 3 | Gem Investment Advisors, LLC | 4.81% | 2.0M | $8.1M | +358,733 (+21.9%) | June 30, 2026 |
| 4 | BlackRock Inc | 3.87% | 1.6M | $6.5M | +1.5M (+1,644.3%) | June 30, 2026 |
| 5 | Murchinson Ltd. | 3.10% | 1.3M | $5.3M | −25,000 (−1.9%) | June 30, 2026 |
| 6 | BML Capital Management LLC | 2.08% | 866K | $3.5M | −2.3M (−72.6%) | June 30, 2026 |
| 7 | BOOTHBAY FUND MANAGEMENT, LLC | 1.39% | 579K | $2.4M | −22,078 (−3.7%) | June 30, 2026 |
| 8 | Geode Capital Management, LLC | 1.20% | 501K | $2.0M | +476,408 (+1,962.0%) | June 30, 2026 |
| 9 | The Goldman Sachs Group Inc | 0.61% | 253K | $1.0M | +253,293 (0.0%) | June 30, 2026 |
| 10 | State Street Corp | 0.58% | 242K | $985,347 | +242,100 (0.0%) | June 30, 2026 |
| 11 | Rathbone Brothers PLC | 0.56% | 233K | $948,383 | −233,018 (−50.0%) | June 30, 2026 |
| 12 | Vanguard Portfolio Management, LLC | 0.55% | 230K | $935,620 | +229,882 (0.0%) | June 30, 2026 |
| 13 | Dimensional Fund Advisors, Inc. | 0.49% | 203K | $824,619 | +44,400 (+28.1%) | June 30, 2026 |
| 14 | Northern Trust Corp | 0.44% | 185K | $752,624 | +184,920 (0.0%) | June 30, 2026 |
| 15 | Renaissance Technologies Corp | 0.44% | 184K | $748,066 | +36,100 (+24.4%) | June 30, 2026 |
| 16 | Wells Fargo & Co | 0.40% | 166K | $675,620 | +8,414 (+5.3%) | June 30, 2026 |
| 17 | Bank of America Corp | 0.36% | 151K | $613,325 | +4,542 (+3.1%) | June 30, 2026 |
| 18 | STRS OHIO | 0.32% | 134K | $544,566 | +133,800 (0.0%) | June 30, 2026 |
| 19 | Jane Street Group LLC | 0.27% | 113K | $461,330 | +60,809 (+115.7%) | June 30, 2026 |
| 20 | O'Shaughnessy Asset Management LLC | 0.25% | 103K | $419,055 | −13,401 (−11.5%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 15 holders added 5.8M shares and 5 cut 2.6M.
ORMP top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | iShares Russell 2000 ETF | 2.03% | 845K | $3.4M | −9,728 (−1.1%) | September 30, 2026 |
| 2 | Fidelity Small Cap Index | 0.91% | 378K | $1.5M | +2,025 (+0.5%) | July 31, 2026 |
| 3 | iShares Russell 2000 Value ETF | 0.77% | 320K | $1.3M | +486 (+0.2%) | September 30, 2026 |
| 4 | Vanguard Russell 2000 ETF | 0.49% | 203K | $824,513 | +6,134 (+3.1%) | September 30, 2026 |
| 5 | iShares Micro-Cap ETF | 0.26% | 110K | $446,617 | −757 (−0.7%) | September 30, 2026 |
| 6 | Schwab Small Cap Index | 0.20% | 84K | $340,390 | — | August 31, 2026 |
| 7 | iShares Russell 2000 Small-Cap Idx Instl | 0.15% | 64K | $258,917 | — | August 31, 2026 |
| 8 | Goldman Sachs ActiveBeta® US SmCp Eq ETF | 0.14% | 60K | $245,055 | — | September 30, 2026 |
| 9 | Avantis US Small Cap Equity ETF | 0.13% | 56K | $226,386 | — | September 30, 2026 |
| 10 | Fidelity Small Cap Value Index | 0.12% | 50K | $204,965 | +1,613 (+3.3%) | July 31, 2026 |
| 11 | Nuveen Small Cap Blend Idx R6 | 0.11% | 46K | $188,864 | — | August 31, 2026 |
| 12 | Dimensional US Small Cap ETF | 0.10% | 40K | $164,766 | — | September 30, 2026 |
| 13 | Dimensional US Core Equity 2 ETF | 0.09% | 37K | $148,702 | — | September 30, 2026 |
| 14 | EQ/2000 Managed Volatility IB | 0.08% | 34K | $136,528 | — | August 31, 2026 |
| 15 | Vanguard Russell 2000 Value ETF | 0.08% | 33K | $134,273 | +1,423 (+4.5%) | September 30, 2026 |
| 16 | Nationwide Bailard Sm Cp Val M | 0.08% | 32K | $132,185 | — | September 30, 2026 |
| 17 | Xtrackers Russell 2000 ETF 1C | 0.07% | 29K | $118,771 | −1,961 (−6.3%) | September 30, 2026 |
| 18 | LVIP SSgA Small Cap Index Std | 0.06% | 26K | $104,599 | +25,700 (0.0%) | June 30, 2026 |
| 19 | Datamira LS World Fund F EUR Acc | 0.06% | 26K | $104,249 | +25,614 (0.0%) | September 30, 2026 |
| 20 | DFA US Core Equity 2 I | 0.06% | 23K | $95,030 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
ORMP insider transactions
latest 2| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2025-01-10 | Brad Knott | Sell | $2.39 | — | — |
| 2023-03-16 | Nadav Kidron | Buy | $2.04 | 26,000 | $53,040 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
ORMP shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns ORMP
Institutional investors own 45.1% of Oramed Pharmaceuticals's shares and insiders 21.27%. The largest holder is Mercer Global Advisors Inc. with 9.16% of the shares (3.8M), as of June 30, 2026. Among the top 20 institutions, 15 added shares and 5 reduced their stake in the latest filings. Short interest is 4.16% of the float, or 7.52 days of average trading volume. The share count rose 298.9% since 2014.
Related: ORMP analyst forecast, ORMP key metrics. See the ORMP stock overview for the latest quote and news.
ORMP ownership FAQ
Who owns the most Oramed Pharmaceuticals stock?
The largest shareholders of Oramed Pharmaceuticals are Mercer Global Advisors Inc. (9.16%), Aquamarine Financial (Cayman) Ltd (6.04%), Gem Investment Advisors, LLC (4.81%), BlackRock Inc (3.87%), Murchinson Ltd. (3.10%).
What percentage of Oramed Pharmaceuticals is owned by institutions?
Institutions hold 45.1% of Oramed Pharmaceuticals's shares outstanding; insiders hold 21.27%.
Which funds own Oramed Pharmaceuticals?
The largest fund holders of Oramed Pharmaceuticals are iShares Russell 2000 ETF (2.03%), Fidelity Small Cap Index (0.91%), iShares Russell 2000 Value ETF (0.77%), Vanguard Russell 2000 ETF (0.49%), iShares Micro-Cap ETF (0.26%).
What is Oramed Pharmaceuticals's short interest?
1.4M shares of Oramed Pharmaceuticals were sold short, 4.16% of the float; at the average daily volume it would take 7.52 days to cover.
Are insiders buying or selling Oramed Pharmaceuticals?
Of the latest 2 reported insider transactions in Oramed Pharmaceuticals (since March 16, 2023), 1 were purchases and 1 were sales.
How many shares of Oramed Pharmaceuticals are outstanding?
Oramed Pharmaceuticals has 41.6M shares outstanding, of which 29.8M are in the public float.